Advertisement

Paroxysmale Lähmungen

  • B. Tettenborn
Chapter
  • 795 Downloads

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  1. Antiplatelet Trialists’ Collaboration (1988) Secondary prevention of vascular disease by prolonged antiplatelet treatment. BMJ 296:320–331Google Scholar
  2. Antiplatelet Trialists’ Collaboration (1994) Collaborative overview of randomized trials of antiplatelet therapy. I: Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients. BMJ 308:81–106Google Scholar
  3. Antithrombotic Trialists’ Collaboration (2002) Collaborative meta-analysis of randomized trials of antiplatelet therapy for death, myocardial infarction, and stroke in high risk patients. BMJ 524:71–86Google Scholar
  4. Bäzner H, Daffertshofer M, Hennerici M (2003) Subkortikale Vaskuläre Enzephalopathie. Akt Neurol 30:266–280Google Scholar
  5. Bassetti C, Aldrich MS (2000) Narcolepsy, idiopathic hypersomnia, and periodic hypersomnias. In: Culebras A (ed) Sleep disorders and neurological disease. Marcel Dekker, New York Basel, pp 323–354Google Scholar
  6. Bennett CL, Connors JM, Carwile JM et al. (2000) Thrombocytic thrombocytopenic purpura associated with clopidogrel. N Engl J Med 342:1773–1777CrossRefPubMedGoogle Scholar
  7. Berlit P (1999) Schlaganfall — Differentialdiagnostische Übersicht. In: Berlit P (Hrsg) Klinische Neurologie. Springer, Berlin Heidelberg New York Tokio, S 954–963Google Scholar
  8. CAPRIE Steering Committee (1996) A randomised, blinded trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). Lancet 348:1329–1339Google Scholar
  9. CAVATAS (2001) Endovascular versus surgical treatment in patients with carotid stenosis in the Carotid and Vertebral Artery Transluminal Angioplasty Study (CAVATAS): a randomized trial. Lancet 357:1729–1737Google Scholar
  10. Department of Health and Human Services and FDA (1998) Internal analgesic, antipyretic, and antirheumatic drug products for over the counter human use. Final rule for professional labelling of aspirin, buffered aspirin and aspirin in combination with antacid drug. Int J Clin Pract 63:56802–56819Google Scholar
  11. Diener HC, Forbes C, Riekkinen P, Sivenius J, Smets P, Lowenthal A and the ESPS group (1997) European Stroke Prevention Study 2: Efficacy and safety data. J Neurol Sci 151:S1–S77CrossRefGoogle Scholar
  12. Diener HC, Hamann GF (2003) Primäre und sekundäre Prävention der zerebralen Ischämie. In: Brandt T, Dichgans J, Diener HC (Hrsg) Therapie und Verlauf neurologischer Erkrankungen, 4. Aufl. Kohlhammer, Stuttgart, S 359–376Google Scholar
  13. Dieterich M, Brandt T (1998) Syndrome mit Störungen der Okulomotorik. In: Stöhr M, Brandt T, Einhäupl KM (Hrsg) Neurologische Syndrome in der Intensivmedizin, 2. Aufl. Kohlhammer, Stuttgart Berlin Köln, S 150–186Google Scholar
  14. European Atrial Fibrillation Trial Study Group (1993) Secondary prevention in non-rheumatic atrial fibrillation after transient ischemic attack or minor stroke. Lancet 342:1255–1262Google Scholar
  15. European Carotid Surgery Trialists’ Collaborative Group (ECST)(1991) MRC European Carotid Surgery Trial: interim results for symptomatic patients with severe (70–99%) or with mild (0–29%) carotid stenosis. Lancet 337:1235–1243Google Scholar
  16. European Stroke Initiative (2004) Recommendations for stroke management: update 2003. Prevention. Cerebrovasc Dis 17[Suppl 2]:15–29Google Scholar
  17. Hertel K, Stephan M, Zierz S (1999) Entzündliche, endokrine und toxische Muskelerkrankungen. In: Berlit P (Hrsg) Klinische Neurologie. Springer, Berlin Heidelberg New York Tokio, S 263–278Google Scholar
  18. Honda Y (1988) Clinical features of narcolepsy: Japanese experiences. In: Honda Y, Juji T (eds) HLA in narcolepsy. Springer, Berlin Heidelberg New York Tokyo, pp 24–57Google Scholar
  19. Hublin S, Kaprio J, Partinen M et al. (1994) The prevalence of narcolepsy: an epidemiological study of the Finnish twin cohort. Ann Neurol 35: 709–716CrossRefPubMedGoogle Scholar
  20. Johnston ST, Gress DR, Browner WS, Sidney S (2000) Shortterm prognosis after emergency department diagnosis of TIA. JAMA 284:2901–2906CrossRefPubMedGoogle Scholar
  21. Klötzsch C, Popescu O (1999) Zerebrale Ischämien. In: Berlit P (Hrsg) Klinische Neurologie. Springer, Berlin Heidelberg New York Tokio, S 963–988Google Scholar
  22. Kömpf D (1995) Die optomotorischen Hirnnerven: Nervus oculomotorius (III), Nervus trochlearis (IV), Nervus abducens (VI). In: Schmidt D, Malin J-P (Hrsg) Erkrankungen der Hirnnerven, 2. Aufl. Thieme, Stuttgart New York, S 58–134Google Scholar
  23. Lee MS, Choi YC, Heo JH, Choi IS (1994) »Drop attacks« stiffening of the right leg associated with posterior fossa arachnoid cyst. Mov Disord 9:377–378PubMedGoogle Scholar
  24. Lempert T, Bauer M, Schmidt D (1994) Syncope: a videometric analysis of 56 episodes of transient cerebral hypoxia. Ann Neurol 36:233–237CrossRefPubMedGoogle Scholar
  25. Malin J-P (1995) Nervus facialis. In: Schmidt D, Malin J-P (Hrsg) Erkrankungen der Hirnnerven, 2. Aufl. Thieme, Stuttgart New York, S 172–204Google Scholar
  26. Mas JL, Arquizan C, Lamy C et al. (2001) Patent Foramen Ovale and Atrial Septal Aneurysm Study Group. Recurrent cerebrovascular events associated with patent foramen ovale, atrial septal aneurysm, or both. N Engl J Med 345:1740–1746CrossRefPubMedGoogle Scholar
  27. Meisner I, Wiebers DO, Swanson JW, O’Fallon WM (1986) The natural history of drop attacks. Neurology 36:1029–1034Google Scholar
  28. North American Symptomatic Carotid Endarterectomy Trial Collaborators (NASCET) (1991) Beneficial effect of carotid endarterectomy in symptomatic patients with high-grade carotid stenosis. N Engl J Med 325:445–453Google Scholar
  29. Remler BF, Daroff RB (1996) Falls and drop attacks. In: Bradley WG, Daroff RB, Fenichel GM, Marsden CD (eds) Neurology in clinical practice. Principles of diagnosis and management, vol I, 2nd edn. Butterworth-Heinemann, Boston, pp 23–28Google Scholar
  30. Rothwell PM, Eliasziv M, Gutnikov SA et al. (2003) Analysis of pooled data from the randomized controlled trials of endarterectomy for symptomatic carotid stenosis. Lancet 361:107–116PubMedGoogle Scholar
  31. Sareen D (2001) Ictal hemiparesis: differentiation from stroke. J Assoc Physicians India 49:838–840PubMedGoogle Scholar
  32. Siegel JM, Moore R, Thannickal T, Nienhuis R (2001) A brief history of hypocretin/orexin and narcolepsy. Neuropsychopharmacology 25[Suppl 5]:S14–S20PubMedGoogle Scholar
  33. Tettenborn B, Bredel-Geissler AE, Krämer G (1999) Die Epilepsien. In: Berlit P (Hrsg) Klinische Neurologie. Springer, Berlin Heidelberg New York Tokio, S 749–808Google Scholar
  34. Witt TN, Mayr-Pfister L, Swash M (1996) Disorders of nerve roots due to bony and disc diseases. In: Brandt T, Caplan LR, Dichgans J, Diener HC, Kennard C (eds) Neurological disorders. Course and treatment. Academic Press, San Diego New York Boston, pp 899–912Google Scholar

Weiterführende Literatur

  1. Berlit P (Hrsg) (1999) Klinische Neurologie. Springer, Berlin Heidelberg New York TokioGoogle Scholar
  2. Mumenthaler M, Stöhr M, Müller-Vahl H (Hrsg) (2003) Läsionen peripherer Nerven und radikuläre Syndrome, 8. Aufl. Thieme, Stuttgart New YorkGoogle Scholar
  3. Mumenthaler M (Hrsg) (1997) Neurologische Differentialdiagnostik, 4. Aufl. Thieme, Stuttgart New YorkGoogle Scholar
  4. Poeck K, Hacke W (Hrsg) (2001) Neurologie, 11. Aufl. Springer, Berlin Heidelberg New York TokioGoogle Scholar

Copyright information

© Springer Medizin Verlag Heidelberg 2005

Authors and Affiliations

  • B. Tettenborn
    • 1
  1. 1.Klinik für NeurologieKantonsspital St. GallenSt. GallenSchweiz

Personalised recommendations